GlassScriptPhysician profile
Hardik Patel
NPI 1265010888
$639.98
in general payments reported to CMS, 2019-2025
7 companies · $620 in 2025
The $620 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $20.25 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.47 |
| Education | $119.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $189.65 | 2025 | Micra, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $140.08 | 2025 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $109.79 | 2025 | |
| Alnylam Pharmaceuticals INC. | $70.86 | 2025 | Amvuttra |
| Amgen INC. | $47.54 | 2025 | Repatha |
| La Jolla Pharmaceutical Company | $43.31 | 2025 | Giapreza |
| Chiesi USA, INC. | $38.75 | 2024-2025 | Cleviprex, Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hardik Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.